![Scott Jeffers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Jeffers
Chief Tech/Sci/R&D Officer at
GENSIGHT BIOLOGICS S.A.
Profile
Scott Jeffers is currently the Chief Technical Officer at Gensight Biologics SA since 2022.
Previously, he worked as the Director-Gene Therapy at Selecta Biosciences, Inc. and as the VP-CMC Process Development & Manufacturing at Redpin Therapeutics, Inc. Dr. Jeffers completed his undergraduate degree at Colorado State University and holds a doctorate from Purdue University.
Scott Jeffers active positions
| Companies | Position | Start |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Chief Tech/Sci/R&D Officer | 01/04/2022 |
Former positions of Scott Jeffers
| Companies | Position | End |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Redpin Therapeutics, Inc.
 Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders | Corporate Officer/Principal | - |
Training of Scott Jeffers
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
22
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Colorado State University
 Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gensight Biologics SA
 Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders | Commercial Services |
- Stock Market
- Insiders
- Scott Jeffers
